Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $5,988 - $6,649
94 Added 3.09%
3,135 $200,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $10,842 - $12,297
-165 Reduced 5.15%
3,041 $210,000
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $219,546 - $259,974
3,206 New
3,206 $230,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fi3 Financial Advisors, LLC Portfolio

Follow Fi3 Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fi3 Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fi3 Financial Advisors, LLC with notifications on news.